Ranbaxy Launches Flotral Prescription Medicine For Prostate Gland Enlargement

Ranbaxy Laboratories Ltd has announced the launch of its benign prostatic hyperplasia (BPH) formulation, Flotral 10 mg. It is a new uro-selective alpha1-blocker, prescription medicine that provides effective relief from signs and symptoms of BPH, a urological disorder.

“Flotral (alfuzosin), once a day medication, has been developed using the Novel Drug Delivery System (NDDS) technology platform, resulting in better patient compliance,” the company said in a statement.

It is a new, convenient and safe formulation. Extensive clinical studies demonstrate that alfuzosin is highly selective resulting in lower incidence of side effects such as postural hypotension and syncope. Alfuzosin also has a low risk of sexual side effects whereas erectile dysfunction (ED) and ejaculatory disorders are well-recognised side effects of other alpha-blockers.

BPH, is caused due to enlargement of the prostate gland and commonly affects the ageing male population. Over 50% of men above the age of 60 and around 80% beyond the age of 80, suffer from BPH worldwide. “If left untreated, BPH can lead to serious health problems, including urinary tract infections, bladder and kidney damage, bladder stones and inability to hold urine,” it added.

“The launch of Flotral further expands Ranbaxy’s key strategic product portfolio and establishes the company’s commitment to build its urology franchise through its competitive edge technology of NDDS,” Sanjeev I Dani, regional director-India, Ranbaxy, stated.

"Morning After Women's Emergency Birth Control Pill" First drug dose should be taken within 72 hours of intercourse. 2 FDA approved pills can be ordered online without an advance prescription from a doctor. Discreet delivery and Fast next day USA express shipping available. $20 off on refills. Click for more drug information and to buy now!

Ranbaxy Laboratories Limited, India's largest Rx pharmaceutical company, manufactures and markets branded generic drugs and Active Pharmaceutical Ingredients. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. Ranbaxy's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies" resulting in a number of products under development. The Company is selling its products in over 100 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 34 countries and manufacturing operations in 7 countries.

HGH News Articles
hgharticles.com (Press Release)
Documented reports and categories like HGH precursors, HGH benefits and the impact of aging on sex.
In the past 50 years, scientists have studied this substance and found it to be a virtual "fountain of youth" in terms of positive effects for the body, mind and energy levels. It is now undeniable that there is a direct correlation between decreased levels of HGH as we age and the undesirable effects of aging.